General Updates

August 19, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street, Bandra (E), Mumbai - 400 051 Mumbai- 400 001 (SYMBOL: THYROCARE) (SCRIP CODE 539871) Sub : Intimation under Regulation 30 read with Regulation 30A and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding complete discharge and release of Transaction Documents pursuant to full redemption and repayment of Non-Convertible Debentures by API Holdings Limited Dear Sir/Madam, Further to our previous disclosures dated September 15, 2025, August 13, 2026 and August 17, 2026, regarding the Non-Convertible Debentures (“NCDs”) issued by API Holdings Limited (the ultimate holding company of Thyrocare Technologies Limited), which were secured by a pledge of equity shares held by Docon Technologies Private Limited (“Docon”) in the Company, and the subsequent release of such pledge, we hereby inform you that we have received a communication from Docon stating that Catalyst Trusteeship Limited, acting as the Debenture Trustee, issued the No-Dues and Release Certificate on August 19, 2026, confirming the complete discharge of all obligations under the NCDs and the Transaction Documents. The relevant details are set out below: Sr. No Events/Information Details 1 Date of initial disclosure of September 15, 2025 the execution of the agreement to the Stock Exchange 2 Brief details of Termination The NCDs issued by API, aggregating to INR 1,700 crore, of agreement were secured by pledge of equity shares representing 60.92% of the equity share capital of the Company held by Docon. Upon full redemption and repayment of the NCDs, the pledge has been fully released and the Transaction Documents stand discharged and are no longer operative or effective. 3 Name(s) of parties with 1. Docon Technologies Private Limited whom the agreement was 2. API Holdings Limited entered 3. AHWSPL India Private Limited 4. Catalyst Trusteeship Limited 4 Nature of the agreement Transaction Documents (Debenture Trust Deed, Debenture Trustee Agreement, Deed of Hypothecation, Share Pledge Agreements and Deeds of Guarantee) 5 Date of execution of the September 11, 2025 (Original Execution date of Transaction agreement Documents) August 19, 2026 (No dues and release certificate received from Debenture Trustee) 6 Reason for terminating the Full redemption and repayment of the NCDs by API, agreement resulting in the discharge of the related Transaction Documents and complete release of the pledge over the equity shares of the Company. 7 Details of impact of No impact on the Company. The pledge over the equity termination of the shares has been fully released and all obligations under the Agreement Transaction Documents have been discharged. We request you to kindly take the same on your records. For Thyrocare Technologies Limited Brijesh Kumar Company Secretary and Compliance Officer